Dalip currently serves as the scientific development lead for the Cell Therapy Technologies portfolio at Terumo BCT. He holds a doctorate degree and conducted post-doctoral studies at Thomas Jefferson University, School of Medicine. Prior to Terumo BCT, Dalip was engaged in the development of technologies & methods for use in autologous cell therapy applications. Throughout his career, Dalip has authored multiple scientific publications and is a co-inventor on several patents & patent applications.
Laboratory Scientist at
Annie Cunningham, is a Laboratory Scientist at Terumo BCT, were she’s leading projects on the quantum cell expansion system, and the FINIA fill and finish system.Annie spent most of her career in the biotechnology industry, before shifting focus into immunotherapy, and contributing to the development of the CART program. And she’s continued her research into the human immune system at the University of Colorado.